IS4152A - Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra - Google Patents

Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra

Info

Publication number
IS4152A
IS4152A IS4152A IS4152A IS4152A IS 4152 A IS4152 A IS 4152A IS 4152 A IS4152 A IS 4152A IS 4152 A IS4152 A IS 4152A IS 4152 A IS4152 A IS 4152A
Authority
IS
Iceland
Prior art keywords
production
water
camptothecin derivatives
soluble camptothecin
soluble
Prior art date
Application number
IS4152A
Other languages
English (en)
Inventor
Joseph Luzzio Michael
Mark Besterman Jeffrey
G. Evans Michael
Leslie Myers Peter
Original Assignee
Glaxo Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc. filed Critical Glaxo Inc.
Publication of IS4152A publication Critical patent/IS4152A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IS4152A 1993-04-29 1994-04-25 Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra IS4152A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5458593A 1993-04-29 1993-04-29
US8104293A 1993-06-22 1993-06-22

Publications (1)

Publication Number Publication Date
IS4152A true IS4152A (is) 1994-10-30

Family

ID=26733234

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4152A IS4152A (is) 1993-04-29 1994-04-25 Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra

Country Status (10)

Country Link
EP (1) EP0696285A1 (is)
JP (1) JPH08509740A (is)
AP (1) AP9400638A0 (is)
AU (1) AU6777194A (is)
CA (1) CA2161681A1 (is)
IL (1) IL109470A0 (is)
IS (1) IS4152A (is)
MY (1) MY141374A (is)
PE (1) PE52894A1 (is)
WO (1) WO1994025466A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6504029B1 (en) * 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
SG104284A1 (en) * 1996-10-30 2004-06-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
US6559309B2 (en) 1996-11-01 2003-05-06 Osi Pharmaceuticals, Inc. Preparation of a camptothecin derivative by intramolecular cyclisation
US6046209A (en) * 1997-05-27 2000-04-04 Smithkline Beecham Corporation Water soluble camptothecin analogs
IN189180B (is) * 1997-07-09 2003-01-04 Chong Kun Dang Corp
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0418099T3 (da) * 1989-09-15 2002-04-02 Res Triangle Inst Fremgangsmåde til fremstilling af 10,11-methylendioxy-20(RS)-camptothecin og 10,11-methylendioxy-20(S)-camptothecinanaloger
ATE136898T1 (de) * 1991-10-29 1996-05-15 Glaxo Wellcome Inc Wasserlösliche camptothecinderivate
CA2087898A1 (en) * 1992-01-24 1993-07-25 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use

Also Published As

Publication number Publication date
JPH08509740A (ja) 1996-10-15
AP9400638A0 (en) 1995-10-28
AU6777194A (en) 1994-11-21
MY141374A (en) 2010-04-16
CA2161681A1 (en) 1994-11-10
PE52894A1 (es) 1995-01-06
WO1994025466A1 (en) 1994-11-10
EP0696285A1 (en) 1996-02-14
IL109470A0 (en) 1994-07-31

Similar Documents

Publication Publication Date Title
IS4092A (is) Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
IS3805A (is) Amínósýruafleiður og aðferð við framleiðslu þeirra
IS3936A (is) Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
IS3718A7 (is) Amínóbenzodiazepines og aðferð til framleiðslu þess
IS4940A (is) Erýtrómýsín og aðferð við að framleiða þau
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
PL315174A1 (en) Novel derivatives of gingolydes and method of obtaining them
DK50489D0 (da) Lyslederkonnektor og fremgangsmaade til fremstilling heraf
DK50889A (da) Cyclomaltodextringlucantransferase og fremgangsmaade til fremstilling heraf
PL305288A1 (en) Novel piperidine derivatives, method of obtaining them and pharmaceutical agent
IS3792A7 (is) Benzodiazepinones og aðferð til framleiðslu þess
DK0774086T3 (da) Kædeled, forbindelsesstykke til kædeled og fremgangmåde til fremstilling deraf
AU4186989A (en) Hollow jewellery objects and method
IS3857A (is) Karboxýl-sýruafleiður og aðferð til framleiðslu þeirra
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
IS3603A7 (is) Brennslukol og aðferð til framleiðslu þeirra
DK223089A (da) Lysdaemper og fremgangsmaade til fremstilling deraf
IS3951A (is) Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
IS4152A (is) Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
NO174334C (no) Fremgangsmåte og innretning til fremstilling av fiberplater
IS1748B (is) Fóður og aðferð við framleiðslu þess
IS4779A (is) Aðferð til að framleiða felódipín og aðferð til að framleiða lyfjablöndu
IS1742B (is) Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)alkanafleiður og notkun þeirra við að vernda taugar
IS3725A7 (is) Amínósýruafleiður og aðferð til framleiðslu þeirra